Africa: New Dosing Guidance for Dolutegravir Allows Neonates Born to Mothers with HIV to Access this ARV Drug for the First Time - CROI Research: [Stellenbosch University] San Francisco -- The PETITE-DTG study evaluated dolutegravir (DTG) -- a drug that revolutionized HIV treatment in adults and children -- in infants less than 28 days old, using a pediatric 5 mg dispersible tablet (DTG-DT) and a novel 5 mg oral…
http://newsfeed.facilit8.network/TJRzrt #HIV #Dolutegravir #ARV #Pediatrics #HealthResearch